Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study.

By M. Sabatine, C. Cannon, C. Gibson, J. López-Sendón, G. Montalescot, P. Théroux, B. Lewis, S. Murphy, C. Mccabe, E. Braunwald. Journal of the American Medical Association (JAMA), 2005

750 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/4c9c31222ef11c9ddd01c1c6269aff450bd22957

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

In Surgery

Citations in the corpus

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2016, neutral): “, 2005 (30) 16143698 Aim: Determine if clopidogrel pretreatment before PCI in pts with recent STEMI is superior to clopidogrel treatment initiated at the time of PCI in preventing MACE”
2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2008, background): “008).(86) There was no significant difference in the rates of the composite of TIMI major or minor bleeding in the pretreatment versus nonpretreatment groups (2.”